What will Silence Therapeutics’ SANRECO Phase 2 results reveal about divesiran in polycythemia vera?
Silence Therapeutics will reveal Phase 2 SANRECO divesiran results in polycythemia vera, testing hematocrit control and phlebotomy reduction.
Pharma & Biotech